Expansion of government screening programs, rise in prevalence of hepatitis c & need for its early detection, and advancements in diagnostic technologies drive the growth of the global hepatitis C ...

With an ever increasing number of patients being treated with IVIg for a wide array of immune-mediated disease, it is important that passive antibody transfer is considered when unexpected ...

Adult antibody thresholds are currently used to determine whether immunocompromised children should get a measles, mumps, and ...

Researchers assessed epidemiologic trends of incident hepatitis C virus infection among patients with HIV infection engaged in care in the US.

Strategic transformation ongoing, positioning the Company as a focused leader in immunology and inflammatory diseasesHighly differentiated, ...

A neutralising antibody (NAb) is an antibody that fully defends its target ... They had no prior history of virological failure, had a CD4 count of at least 350 and did not have hepatitis B. More than ...

RhIG is a sterile solution that contains immunoglobulin G anti-D antibodies. It is tested for hepatitis C, hepatitis B, parvovirus B19, and HIV, processed via cold ethanol fractionation or the ion ...

A single shot of a new formulation of the antiretroviral drug lenacapavir could potentially provide protection against HIV ...

Sino Biopharm has a good financial position. As of December 2024, it has CNY 9.6 billion in cash on hand and CNY 9.6 billion in debt. Total debt outstanding is 14.7% of its total assets. Its capital ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...